ASSY, CNTRL UNIT, FREEDOM CYCLER (REFURB)

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 04,05,06 report with the FDA on 2014-07-24 for ASSY, CNTRL UNIT, FREEDOM CYCLER (REFURB) manufactured by Fresenius Medical Care North America.

Event Text Entries

[16781004] During a call to technical services regarding an alarm issue regarding the cycler, it was indicated by the patient's mother that the patient had been admitted to the hospital due to an episode of peritonitis. The clinical manager stated the patient was previously admitted to the hospital for peritonitis, was discharged and is currently completing treatments using the new cycler without issue.
Patient Sequence No: 1, Text Type: D, B5


[17076323] The patient was admitted to the hospital on (b)(6) 2014 after his mother reported a one day history of cloudy, purulent effluent peritoneal dialysis (pd) fluid. The patient was hospitalized on (b)(6) 2014 due to bacterial and fungal peritonitis. During this time, he completed a 14 day course of cefepime and fluconazole intra-peritoneally (ip) through his dialysate. On (b)(6) 2014, his effluent pd fluid cultures were positive for enterobacter cloacae and klebsiella pneumoniae. On (b)(6) 2014, pd fluid cultures were positive. The following was based on medical records provided by the patient's treatment facility. He completed a 14 day course of cefepime and fluconazole intra-peritoneally (ip) through his dialysate. On (b)(6) 2014, his effluent pd fluid cultures were positive for enterobacter cloacae and klebsiella pneumoniae. The patient has a history of emesis which has worsened recently as well as baseline loose and frequent stools. The patient was negative for fever and chills. The patient's abdomen was non-tender with no rebound tenderness or guarding. There were normal bowel sounds. His gastrostomy tube site was clean and dry and his pd catheter showed no signs of inflammation. The patient received his last dose of fluconazole in his pd fluid on (b)(6) 2014 and did not start his fluconazole via his gastrostomy tube until (b)(6) 2014. The patient's last positive fungal culture in the pd fluid was on (b)(6) 2014 growing candida famata. His last positive bacterial culture of the pd fluid was on (b)(6) 2014. A supplemental report will be submitted upon completion of the plant's investigation.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2937457-2014-01839
MDR Report Key4016925
Report Source04,05,06
Date Received2014-07-24
Date of Report2014-06-14
Date of Event2014-05-16
Date Mfgr Received2014-06-14
Device Manufacturer Date2000-05-01
Date Added to Maude2014-08-19
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactTANYA TAFT, RN CNOR
Manufacturer Street920 WINTER ST.
Manufacturer CityWALTHAM MA 024511457
Manufacturer CountryUS
Manufacturer Postal024511457
Manufacturer Phone7816999000
Manufacturer G1FRESENIUS MEDICAL CARE NORTH AMERICA
Manufacturer Street4040 NELSON AVE.
Manufacturer CityCONCORD CA 94520
Manufacturer CountryUS
Manufacturer Postal Code94520
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameASSY, CNTRL UNIT, FREEDOM CYCLER (REFURB)
Product CodeKPF
Date Received2014-07-24
OperatorLAY USER/PATIENT
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerFRESENIUS MEDICAL CARE NORTH AMERICA
Manufacturer AddressCONCORD CA US


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization; 2. Required No Informationntervention 2014-07-24

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.